Neuroimaging consistently reveals smaller hippocampal volume in recurrent or chronic major depressive disorder (MDD). The underlying cellular correlates of the smaller volume are not clearly known. Postmortem tissues from 17 pairs of depressed and control subjects were obtained at autopsy, and informant-based retrospective psychiatric assessment was performed. Formalin-fixed left temporal lobes were sectioned (40 μm), stained for Nissl substance, and every 60th section selected throughout the entire hippocampus. Total volume of the hippocampal formation was calculated, and total numbers of pyramidal neurons (in hippocampal fields CA1, CA2/3, hilus), dentate gyrus (DG) granule cells, and glial cells were estimated stereologically. While hippocampal volume in all MDD subjects was not significantly smaller versus control subjects, in recurrent/chronic MDD, total volume decreased with duration of depressive illness (r=−0.696, p<0.026). There was no significant difference between MDD and controls in total number or density of pyramidal neurons/granule cells or glial cells in CA1, CA2/3, hilus, or DG. However, CA1 pyramidal neuron density increased with duration of illness in recurrent/chronic MDD (r=0.840, p<0.002). Granule cell (r=0.971, p<0.002) and glial cell numbers (r=0.980, p<0.001) increased with age in those taking antidepressant medication (n=6). Increasing DG granule cell and glial cell numbers with age in antidepressant-treated subjects may reflect proliferative effects of antidepressant medications. Decreasing total volume and increasing CA1 pyramidal neuron density with duration of illness in recurrent/chronic MDD lends support to the neuropil hypothesis of MDD.
Context:Exposure to maternal adiposity during pregnancy is associated with higher
offspring birth weight and greater adiposity through childhood and adult life. As
birth weight reflects the summation of lean and fat mass, the extent to which fat
mass at birth tracks into later life is unknown.Objective:To determine whether fat mass at birth is associated with child and adolescent
adiposity.Design, Setting, and Participants:UK birth cohort with markers of neonatal fat mass; cord blood leptin, adiponectin,
and birth weight and adiposity outcomes at age 9 (n = 2775) and 17 years (n =
2138).Main Outcomes:Offspring body mass index (BMI), waist circumference, dual-energy X-ray
absorptiometry–determined fat mass, and obesity at age 9 and 17 years.Results:Higher cord blood leptin was associated with higher z scores of
fat mass [difference in mean per 10 pg/mL: 0.03 standard deviation (SD); 95%
confidence interval (CI), 0.00 to 0.06], waist circumference (0.04 SD; 95% CI,
0.00 to 0.07), and BMI (0.04 SD; 95% CI, 0.00 to 0.08) at age 9. However, by age
17 the adjusted results were attenuated to the null. Cord blood adiponectin was
not associated with measures of adiposity at age 9. At age 17, cord blood
adiponectin was positively associated with fat mass (0.02 SD per 10 μg/mL;
95% CI, 0.02 to 0.03) and waist circumference (0.04 SD per 10 μg/mL; 95%
CI, 0.03 to 0.05). Birth weight was positively associated with waist circumference
(0.03 SD per 100 g; 95% CI, 0.02 to 0.04) and BMI (0.02 SD per 100 g; 95% CI, 0.00
to 0.03), but not fat mass or odds of obesity. Cord blood leptin and adiponectin
were not associated with obesity at either age.Conclusions:Increased cord blood leptin and adiponectin, known surrogates of fetal fat mass,
were weakly associated with increased fat mass in late childhood and adolescence,
respectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.